Attana enabled at University of Dublin

Under the supervision of Professor Kenneth A Dawson, the group at CBNI work with Nanomedicine and Nanosafety applications. The aim is to fundamentally understand the interactions between the nanoparticle interface and the biological milieu surrounding it. The milieu is set up by proteins and other biomolecules that forms the nanoparticle interface, the so-called “corona”. The corona forms the bionanointerface that determines the fate and behaviour of nanomaterials.

The group will use the Attana instruments to understand, classify and predict nanoparticle coronas physicochemical properties. This offers a novel approach to screen for toxicity at early stages of product development and for regulatory purposes.

“The Attana Cell 200 will be an important tool complementing our other techniques. We have a tradition of successfully implementing novel technologies into efficient research tools. The ability to perform kinetic interaction analysis between nanoparticles and cells add a crucial aspect in our research” comments Prof. Dawson.